ILIAS Biologics Inc.
Sungkyu Lee has worked in a variety of roles in the legal and medical industries. Sungkyu began their career in 2007 as a Medical Representative for Pfizer Korea. In 2013, they became a Legal Trainee at the Judicial Research & Training Institute. In 2014, they were an intern at UNIDROIT. In 2015, they became an Attorney at Law at Darae Law & IP Firm. In 2016, they opened their own law office as an Attorney at Law. From 2019 to 2021, they worked as in-house counsel in Orum Therapeutics before becoming the Head of Corporate Strategy at ILIAS Biologics Inc.
Sungkyu Lee attended KAIST from 1998 to 2005, where they obtained a Bachelor of Science (B.S.) in Biological sciences. Afterwards, they returned to KAIST from 2005 to 2007 to complete a Master of Science (M.S.) in Biological sciences.
This person is not in any teams
This person is not in any offices
ILIAS Biologics Inc.
2 followers
At ILIAS Biologics, they dedicate themselves to the development of paradigm-shifting advances in human medicine. Their platform technology, EXPLOR, makes it possible to load large therapeutic molecules into exosomes, and they are actively developing various therapeutic exosomes, Exo-Targets, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.